Ben Haynor Analyst PerformanceManaging Director, Medical Technology Research at Lake Street CapitalBen Haynor is a stock analyst at Lake Street Capital focused in the medical sector, covering 16 publicly traded companies. Over the past year, Ben Haynor has issued 12 stock ratings, including and buy recommendations. While full access to Ben Haynor's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Ben Haynor's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings32 Last 10 YearsBuy Recommendations89.66% 26 Buy RatingsCompanies Covered16 Unique Companies Ratings Distribution29RatingsDistribution of strong buy, buy, hold, and sell ratings by Ben Haynor.RatingPercentageCount Strong Buy6.9%2 ratings Buy82.8%24 ratings Hold10.3%3 ratings Sell0.0%0 ratingsOut of 29 total stock ratings issued by Ben Haynor at Lake Street Capital, the majority (82.8%) have been Buy recommendations, followed by 10.3% Hold and 6.9% Strong Buy.Best & Worst CallsBest Call0000.0%TEARApr 2016Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%TEARMar 2017Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ87.5% of companies on NASDAQ14 companiesNYSE6.3% of companies on NYSE1 companyOTCMKTS6.3% of companies on OTCMKTS1 companyBen Haynor, an analyst at Lake Street Capital, currently covers 16 companies listed on NASDAQ, NYSE and OTCMKTS, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical14 companies87.5%Computer and Technology1 company6.3%Manufacturing1 company6.3%Ben Haynor of Lake Street Capital specializes in stock coverage within the Medical sector, with additional focus on Computer and Technology and Manufacturing companies.Coverage IndustriesIndustryPercentageMED INSTRUMENTS9 companies56.3%MEDICAL INFO SYS2 companies12.5%PHARMACEUTICAL PREPARATIONS2 companies12.5%INTERNET SOFTWARE1 company6.3%MEDICAL SERVICES1 company6.3%MED PRODUCTS1 company6.3% Ben Haynor's Ratings History at Lake Street Capital Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsPIIIP3 Health Partners5/15/2026Reiterated Rating$7.76$14.00Buy$0.0000.00% ROIPIIIP3 Health Partners3/27/2026Lower Price Target$2.68$4.00Buy$0.0000.00% ROITMCITreace Medical Concepts3/2/2026Lower Price Target$1.66$7.00Buy$0.0000.00% ROITCMDTactile Systems Technology2/18/2026Set Price Target$34.53$40.00Buy$0.0000.00% ROIBFLYButterfly Network1/20/2026Boost Price Target$4.14$5.50Buy$0.0000.00% ROIPIIIP3 Health Partners11/17/2025Lower Price Target$6.25$12.50Buy$0.0000.00% ROITCMDTactile Systems Technology11/4/2025Boost Price Target$21.99$32.00Buy$0.0000.00% ROIKIDSOrthoPediatrics10/10/2025Lower Price Target$15.64$34.00Buy$0.0000.00% ROITCMDTactile Systems Technology10/3/2025Initiated Coverage$13.97$23.50Buy$0.0000.00% ROIPIIIP3 Health Partners8/28/2025Initiated Coverage$7.85$20.00Buy$0.0000.00% ROISRTSSensus Healthcare8/8/2025Lower Price Target$3.46$6.00Buy$0.0000.00% ROIATECAlphatec6/16/2025Upgrade$11.06$18.00Buy$0.0000.00% ROIBFLYButterfly Network5/5/2025Lower Price Target$2.24$4.00Buy$0.0000.00% ROIKIDSOrthoPediatrics4/7/2025Initiated Coverage$22.70$37.00Buy$00.0000.00% ROILFWDLifeward3/11/2025Lower Price Target$16.20$48.00Buy$0.0000.00% ROICHRNChronoScale Corporation Common Stock3/4/2025Lower Price Target$7.14$15.00Buy$00.0000.00% ROILFWDLifeward2/20/2025Lower Price Target$22.02$54.00Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel NicolausRaymond James Financial Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
